Dr. Earl S. Brown Professional Corp Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3612 Avenue F, Bay City, TX 77414 Phone: 979-240-1450 Fax: 979-244-3122 |
Tso Bay City, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 4310 7th St Ste 400, Bay City, TX 77414 Phone: 979-297-8188 Fax: 979-297-5410 |
Earl Stanley Brown, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3612 Ave F, Bay City, TX 77414 Phone: 979-244-1450 Fax: 979-244-3122 |
Mann Eye Center, Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3612 Avenue F, Bay City, TX 77414 Phone: 979-244-1440 Fax: 979-244-3122 |
Berkeley Eye Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6500 7th St Ste 200, Bay City, TX 77414 Phone: 979-318-3204 Fax: 979-318-3208 |
Eyecon Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4600 7th St, Bay City, TX 77414 Phone: 832-971-8910 |
News Archive
T2 Biosystems, Inc., a company developing next-generation medical diagnostic products, today announced that it has relocated to a newly renovated 20,000 sq.ft. facility located in Lexington, MA.
Living with HIV is difficult under the best of circumstances, but for people carrying the virus, alcohol consumption can become particularly perilous in intricate ways that are only beginning to be understood. At the Brown Alcohol Research Center on HIV (ARCH) funded by a new $7.5-million, five-year grant from the National Institutes of Health, Brown University scientists will study the health effects of drinking with HIV and provide doctors and patients with the latest guidance their results suggest.
In the first three years of Medicaid expansion due to the Affordable Care Act, the number of patients with end-stage kidney disease who died within a year of starting dialysis decreased in states that expanded Medicaid compared to non-expansion states, new research found.
Leuven scientists (VIB/KU Leuven) are using zebrafish as a model in their search for genes that play a role in the mechanism of amyotrophic lateral sclerosis (ALS). As a result, they have identified a molecule that could be the target for a future ALS treatment.
› Verified 7 days ago